Premium
IC‐PL‐03: Topographical Markers of Alzheimer's Disease Progression: Can MRI and FDG‐PET Serve as Surrogate Outcomes in Clinical Trials of Disease Modifying Agents in Alzheimer's Disease?
Author(s) -
Jicha Gregory
Publication year - 2011
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2011.05.2431
Subject(s) - disease , clinical trial , medicine , pathological , pathology , neuroscience , psychology